CN102186875A - 较高细胞密度的澄清方法 - Google Patents
较高细胞密度的澄清方法 Download PDFInfo
- Publication number
- CN102186875A CN102186875A CN2009801405074A CN200980140507A CN102186875A CN 102186875 A CN102186875 A CN 102186875A CN 2009801405074 A CN2009801405074 A CN 2009801405074A CN 200980140507 A CN200980140507 A CN 200980140507A CN 102186875 A CN102186875 A CN 102186875A
- Authority
- CN
- China
- Prior art keywords
- cell
- culture fluid
- biological agents
- supernatant layer
- cell culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 49
- 238000005352 clarification Methods 0.000 title abstract description 13
- 230000008569 process Effects 0.000 title description 2
- 210000004027 cell Anatomy 0.000 claims abstract description 156
- 239000006228 supernatant Substances 0.000 claims abstract description 44
- 239000000463 material Substances 0.000 claims abstract description 22
- 210000004962 mammalian cell Anatomy 0.000 claims abstract description 18
- 238000005349 anion exchange Methods 0.000 claims abstract description 15
- 239000012930 cell culture fluid Substances 0.000 claims description 47
- 239000003124 biologic agent Substances 0.000 claims description 40
- 238000005277 cation exchange chromatography Methods 0.000 claims description 7
- 238000010790 dilution Methods 0.000 claims description 7
- 239000012895 dilution Substances 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- 108060003951 Immunoglobulin Proteins 0.000 claims description 4
- 102000018358 immunoglobulin Human genes 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 238000011084 recovery Methods 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 5
- 239000008188 pellet Substances 0.000 abstract description 3
- 238000011534 incubation Methods 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 15
- 238000004062 sedimentation Methods 0.000 description 14
- 238000001914 filtration Methods 0.000 description 12
- 239000002953 phosphate buffered saline Substances 0.000 description 11
- 238000004113 cell culture Methods 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 238000004587 chromatography analysis Methods 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 238000005520 cutting process Methods 0.000 description 6
- 239000011324 bead Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 4
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 4
- 238000005189 flocculation Methods 0.000 description 4
- 230000016615 flocculation Effects 0.000 description 4
- 229910010272 inorganic material Inorganic materials 0.000 description 4
- 239000011147 inorganic material Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000012501 chromatography medium Substances 0.000 description 3
- 238000007596 consolidation process Methods 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000011368 organic material Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000001471 micro-filtration Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000008521 reorganization Effects 0.000 description 2
- 239000002195 soluble material Substances 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- JHPBZFOKBAGZBL-UHFFFAOYSA-N (3-hydroxy-2,2,4-trimethylpentyl) 2-methylprop-2-enoate Chemical compound CC(C)C(O)C(C)(C)COC(=O)C(C)=C JHPBZFOKBAGZBL-UHFFFAOYSA-N 0.000 description 1
- 101710153593 Albumin A Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- -1 acryl Chemical group 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 210000004332 phalangeal cell Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229960001814 trypan blue Drugs 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10632008P | 2008-10-17 | 2008-10-17 | |
US61/106,320 | 2008-10-17 | ||
EP08167506 | 2008-10-24 | ||
EP08167506.8 | 2008-10-24 | ||
PCT/EP2009/063565 WO2010043700A1 (en) | 2008-10-17 | 2009-10-16 | Clarification process at higher cell density |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102186875A true CN102186875A (zh) | 2011-09-14 |
Family
ID=40367660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009801405074A Pending CN102186875A (zh) | 2008-10-17 | 2009-10-16 | 较高细胞密度的澄清方法 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2346891A1 (fi) |
JP (1) | JP2012505863A (fi) |
KR (1) | KR20110085980A (fi) |
CN (1) | CN102186875A (fi) |
AU (1) | AU2009305343A1 (fi) |
CA (1) | CA2739501A1 (fi) |
WO (1) | WO2010043700A1 (fi) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012030512A1 (en) | 2010-09-03 | 2012-03-08 | Percivia Llc. | Flow-through protein purification process |
SG10201808061WA (en) | 2013-09-30 | 2018-10-30 | Janssen Vaccines & Prevention Bv | Method for the clarification of high density crude cell culture harvest |
SG10201911134QA (en) | 2015-06-05 | 2020-01-30 | Grace W R & Co | Adsorbent bioprocessing clarification agents and methods of making and using the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030170810A1 (en) * | 2001-09-18 | 2003-09-11 | Masoud Vedadi | Methods and apparatuses for purification |
WO2007123961A2 (en) * | 2006-04-20 | 2007-11-01 | Wyeth | Purification processes for isolating purified vesicular stomatitis virus from cell culture |
-
2009
- 2009-10-16 CN CN2009801405074A patent/CN102186875A/zh active Pending
- 2009-10-16 CA CA2739501A patent/CA2739501A1/en not_active Abandoned
- 2009-10-16 KR KR1020117008313A patent/KR20110085980A/ko not_active Ceased
- 2009-10-16 AU AU2009305343A patent/AU2009305343A1/en not_active Abandoned
- 2009-10-16 WO PCT/EP2009/063565 patent/WO2010043700A1/en active Application Filing
- 2009-10-16 JP JP2011531501A patent/JP2012505863A/ja active Pending
- 2009-10-16 EP EP09820285A patent/EP2346891A1/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030170810A1 (en) * | 2001-09-18 | 2003-09-11 | Masoud Vedadi | Methods and apparatuses for purification |
WO2007123961A2 (en) * | 2006-04-20 | 2007-11-01 | Wyeth | Purification processes for isolating purified vesicular stomatitis virus from cell culture |
Non-Patent Citations (1)
Title |
---|
FRANK RISKE ET AL.,: ""The use of chitosan as a flocculant in mammalian cell culture dramatically improves clarification throughput without adversely impacting monoclonal antibody recovery"", 《JOURNAL OF BIOTECHNOLOGY》 * |
Also Published As
Publication number | Publication date |
---|---|
JP2012505863A (ja) | 2012-03-08 |
CA2739501A1 (en) | 2010-04-22 |
EP2346891A1 (en) | 2011-07-27 |
AU2009305343A1 (en) | 2010-04-22 |
KR20110085980A (ko) | 2011-07-27 |
WO2010043700A1 (en) | 2010-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010043703A1 (en) | Removal of host cell proteins | |
EP1175931A1 (en) | Integration of high cell density bioreactor operation with ultra fast on-line downstream processing | |
Singh et al. | Clarification of recombinant proteins from high cell density mammalian cell culture systems using new improved depth filters | |
JP5785098B2 (ja) | 単一ポリマー相系を用いる分離方法 | |
RU2751506C2 (ru) | Способы обработки текучей среды, содержащей рекомбинантный терапевтический белок, и их применение | |
CN118388581A (zh) | 治疗性蛋白药物物质的整合连续制造 | |
CN102178952A (zh) | 一种层析法提取破伤风人免疫球蛋白的方法 | |
NL8902351A (nl) | Biochemische scheiding van materiaal uit een vloeistofmilieu. | |
CN102186875A (zh) | 较高细胞密度的澄清方法 | |
JP2023145471A (ja) | 容積測定ローディング流量を低減し、そして結合及び溶出クロマトグラフィー精製の生産性を増大するためのインライン生成物濃縮 | |
CN114829371A (zh) | 使用透析过滤缓冲液强化的病毒过滤 | |
US20110184154A1 (en) | Cell broth clarification and host cell protein removal | |
CN105579572B (zh) | 用于净化高密度粗细胞培养收获物的方法 | |
CN109320611B (zh) | 一种人鼠嵌合单克隆抗体生物类似药的纯化方法 | |
WO2021064244A1 (en) | Purification process based on magnetic beads | |
CN102203113A (zh) | 澄清方法 | |
JP2014523405A (ja) | 標的分子精製におけるdna除去法 | |
CN116685383A (zh) | 病毒载体纯化装置及方法 | |
HK1161602A (en) | Clarification process at higher cell density | |
RU2573927C2 (ru) | Способ получения моноклональной линии растительных клеток | |
CN115779683B (zh) | 除病毒过滤方法 | |
HK1161601A (en) | Clarification process | |
Charlton et al. | Filter life after cell death: impact of viable, non-viable apoptotic and necrotic mammalian cells on depth filter blinding | |
Ahmad | RECOMBINANT PROTEIN CREATION AND PURIFICATION | |
Smith | Systematic selection of down stream processing techniques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1161602 Country of ref document: HK |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110914 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1161602 Country of ref document: HK |